Frank Rimerman Advisors’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$204K Buy
+730
New +$192K 0.01% 597
2025
Q4
Sell
-738
Closed -$212K 631
2025
Q3
$212K Sell
738
-26
-3% -$6.97K 0.01% 571
2025
Q2
$201K Buy
+764
New +$186K 0.01% 543

Other funds holding LH

Frank Rimerman Advisors's LH Position: Q2 2026 in Review

Frank Rimerman Advisors opened a new position in Labcorp (LH) in Q2 2026: 730 shares worth $204K. The stake represents 0.01% of the portfolio and ranks #597 among its holdings. This is a return to the name: Frank Rimerman Advisors previously reported a position in LH as recently as Q3 2025.

Frank Rimerman Advisors first reported a position in LH in Q2 2025 and has held it in 3 quarters since. The position peaked at $212K in Q3 2025. 1,057 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • Frank Rimerman Advisors held 730 shares of Labcorp worth $204K as of Q2 2026.
  • Labcorp was a new Frank Rimerman Advisors position in Q2 2026.
  • Labcorp made up 0.01% of Frank Rimerman Advisors's portfolio in Q2 2026, its #597 holding.
  • Frank Rimerman Advisors first reported a position in Labcorp in Q2 2025 and has held it in 3 quarters since.
  • Frank Rimerman Advisors's Labcorp position peaked at $212K in Q3 2025.
  • 1,057 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Frank Rimerman Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.